- Report
- April 2024
- 121 Pages
Global
From €5097EUR$5,500USD£4,257GBP
- Report
- January 2024
- 120 Pages
Global
From €5514EUR$5,950USD£4,606GBP
- Report
- October 2023
- 150 Pages
Global
From €5514EUR$5,950USD£4,606GBP
- Report
- September 2024
- 89 Pages
Global
From €5190EUR$5,600USD£4,335GBP
- Report
- September 2024
- 196 Pages
Global
From €5051EUR$5,450USD£4,219GBP
- Report
- September 2024
- 413 Pages
Global
From €5375EUR$5,800USD£4,490GBP
- Report
- August 2024
- 150 Pages
Global
From €3613EUR$3,899USD£3,018GBP
- Report
- August 2024
- 142 Pages
Global
From €3613EUR$3,899USD£3,018GBP
- Report
- August 2024
- 143 Pages
Global
From €3613EUR$3,899USD£3,018GBP
- Report
- March 2024
- 145 Pages
Global
From €3613EUR$3,899USD£3,018GBP
- Report
- March 2024
- 148 Pages
Global
From €3613EUR$3,899USD£3,018GBP
- Report
- July 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- July 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- July 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- July 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- February 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- February 2024
- 175 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- February 2024
- 200 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- January 2024
- 200 Pages
Global
From €4634EUR$5,000USD£3,870GBP
- Report
- January 2024
- 200 Pages
Global
From €4634EUR$5,000USD£3,870GBP
The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more